Healthcare Global Enterprises Ltd Share Price (HCG)
Check the latest share price of Healthcare Global Enterprises Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 06 Jun 2025
NSE
Healthcare Global Enterprises Ltd Stock Performance
Get live Healthcare Global Enterprises Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹546.9Day's Price Range₹554.9552 Week's Low
52 Week's High
₹330.6552-Week Price Range₹639
| Returns % | |
| 1 Month Return | -0.01 % |
| 3 Month Return | + 9.1 % |
| 1 Year Return | + 51.35 % |
| 3 Year Return | + 95.99 % |
| 5 Year Return | + 361.38 % |
| Market Stats | |
| Previous Close | ₹550.60 |
| Open | ₹547.10 |
| Volume | 1.73L |
| Upper Circuit | ₹660.70 |
| Lower Circuit | ₹440.50 |
Healthcare Global Enterprises Ltd Fundamentals & Key Indicators
Check Healthcare Global Enterprises Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹7,702.70 Cr
Return on Equity (ROE)
3.22
PE Ratio (TTM)
173.2
Return on capital employed (ROCE)
6.23
Industry PE ratio
102.22
Beta (LTM)
0.65
P/B Ratio
3.96
Dividend Yield
0PEG Ratio
-641.47
Quarterly Earnings Growth YOY
-71.14
EPS (TTM)
2.97
Sector
Healthcare
Book Value
59.28
Technical Analysis
Bearish
View Technical Analysis
How to invest in Healthcare Global Enterprises Ltd?
Investing in Healthcare Global Enterprises Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Healthcare Global Enterprises Ltd or HCG on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Healthcare Global Enterprises Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Healthcare Global Enterprises Ltd with just a few clicks!
Healthcare Global Enterprises Ltd Stock's Interest Amongst Investors
Healthcare Global Enterprises Ltd Valuation
Track how Healthcare Global Enterprises Ltd P/E has moved over time to understand its valuation trends.
Healthcare Global Enterprises Ltd in the last 5 years
Lowest (-514.24x)
November 27, 2018
Industry (102.22x)
June 6, 2025
Today (173.20x)
June 6, 2025
Highest (201.31x)
July 2, 2018
Today’s Price to Earnings Ratio: 173.20x
Healthcare Global Enterprises Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Healthcare Global Enterprises Ltd.
based on 8 analysts
62.50%
Buy
25.00%
Hold
12.50%
Sell
62.5% of analysts recommend a 'BUY' rating for Healthcare Global Enterprises Ltd. Average target price of ₹571.38
Source: S&P Global Market Intelligence
Healthcare Global Enterprises Ltd Share Price Target
Get share price movements and forecasts by analysts on Healthcare Global Enterprises Ltd.
Healthcare Global Enterprises Ltd price forecast by 8 analysts
Upside of3.42%
High
₹628
Target
₹571.38
Low
₹342
Healthcare Global Enterprises Ltd target price ₹571.38, a slight upside of 3.42% compared to current price of ₹552.5. According to 8 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Healthcare Global Enterprises Ltd revenue growth forecast
Expected growth rate Q1, FY2027:50.81%
Forecast
Actual
Including amortisation and stock based compensations
Healthcare Global Enterprises Ltd EPS growth forecast
EPS estimate Q1, FY2027:179.19%
Forecast
Actual
Source: S&P Global Market Intelligence
Healthcare Global Enterprises Ltd Financial Results
Get the annual and quarterly financial summary of Healthcare Global Enterprises Ltd, including revenue, profit, loss and more.
Indices Featuring Healthcare Global Enterprises Ltd Stock
Check stock indices that include Healthcare Global Enterprises Ltd.
Healthcare Global Enterprises Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Healthcare Global Enterprises Ltd.
Healthcare Global Enterprises Ltd Earnings Results
Healthcare Global Enterprises Ltd’s net profit fell -65.38% since last year same period to ₹7.36Cr in the Q4 2024-2025. On a quarterly growth basis, Healthcare Global Enterprises Ltd has generated 5.44% jump in its net profits since last 3-months.
Read More about Earnings Results
Healthcare Global Enterprises Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Healthcare Global Enterprises Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.22% | 0.00 | |
| Foreign Institutions | 2.45% | 0.00 | |
| Mutual Funds | 9.19% | 0.00 | |
| Retail Investors | 13.86% | 0.00 | |
| Others | 3.29% | 0.00 |
Healthcare Global Enterprises Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Healthcare Global Enterprises Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 7,702.70 | 72.28% | 0.70 | NA | NA | |
| NA | 110.87 | 72.82% | 0.59 | NA | NA | |
| NA | 78.17 | 54.55% | 0.73 | NA | NA | |
| BUY | 3,715.74 | 271.66% | 0.71 | NA | NA | |
| BUY | 1,966.77 | -10.97% | 0.00 | NA | NA |
Healthcare Global Enterprises Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Healthcare Global Enterprises Ltd.
HCG Maintains Buy Rating with Revised Target Price - 27 May, 2025
Prabhudas Lilladher maintains a 'BUY' rating on Healthcare Global Enterprises, setting a target price of Rs 620. The company shows strong EBITDA growth and operational efficiency, supported by KKR's strategic investment. Expected 23% EBITDA CAGR over FY25-27E.Healthcare Global Reports Mixed Financial Results - 26 May, 2025
Healthcare Global Enterprises experienced a 65.38% decline in consolidated net profit for the March 2025 quarter, despite an 18.28% rise in sales. Standalone net sales increased by 15.69%, with a significant profit increase of 676.7%. Overall, the company shows mixed financial performance.HCG Reports Profit Drop Amid Revenue Growth - 24 May, 2025
Healthcare Global Enterprises (HCG) reported a 65% decline in Q4 PAT to ₹7.4 crore, despite an 18% increase in revenue. The company announced the acquisition of the advanced Orbitrap Astral Mass Spectrometer to enhance its diagnostic capabilities.
Insights on Healthcare Global Enterprises Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, HCG stock has moved up by 9.1%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 6.98 Cr → 7.36 Cr (in ₹), with an average increase of 5.2% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 564.11 Cr → 595.39 Cr (in ₹), with an average increase of 5.3% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 13.06% to 13.86% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 69.1% return, outperforming this stock by 13.7%
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 212.0% return, outperforming this stock by 119.3%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 2.77% to 2.45% in Mar 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 10.04% to 9.19% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 71.23% to 71.22% in Mar 2025 quarter
About Healthcare Global Enterprises Ltd
Established in 1998, HCG expanded its operations in 2016 with a successful Initial Public Offering (IPO) and launched advanced cancer centres in Baroda and Visakhapatnam. Later, in 2017, it acquired a majority stake in Cancer Care Kenya, and launched its first cancer centre in Kanpur with 90 dedicated beds. It is also setting up hospitals with high end linear accelerators in Kolkata and Nashik. HCG has been dedicated to delivering quality medical care across diagnosis and treatment, and its latest technologies like Robotic Surgery and Tomotherapy Treatment System are paving the way for a better tomorrow.
Revenue: ₹583.43Cr as on March 2025 (Q4 FY25)
Net Profit: ₹6.77Cr as on March 2025 (Q4 FY25)
Listing date: 30 Mar, 2016
Chairperson Name: BASAVALINGA AJAIKUMAR SADASHIVAIAH
| Organisation | Healthcare Global Enterprises Ltd |
| Headquarters | Bengaluru |
| Industry | Healthcare |
| CEO | BASAVALINGA AJAIKUMAR SADASHIVAIAH |
| E-voting on shares | Click here to vote |
Mutual Funds that own Healthcare Global Enterprises Ltd
Check out the Mutual Funds with significant holdings in Healthcare Global Enterprises Ltd.
FAQs
What is Healthcare Global Enterprises Ltd share price today?
Healthcare Global Enterprises Ltd share price today stands at ₹552.5, Open: ₹547.1, Previous Close: ₹550.6, High: ₹554.95, Low: ₹546.9, 52 Week High: ₹639, 52 Week Low: ₹330.65.
What is today's traded volume of Healthcare Global Enterprises Ltd?
Today's traded volume of Healthcare Global Enterprises Ltd is 1.73L. Which means that 1.73L shares of Healthcare Global Enterprises Ltd were bought and sold on the stock market during today's trading session.
What is Healthcare Global Enterprises Ltd's market cap today?
Today's market capitalisation of Healthcare Global Enterprises Ltd is ₹7,702.70 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd’s 52 week high is ₹639 and 52 week low is ₹330.65. The current share price of Healthcare Global Enterprises Ltd is ₹552.5, which is -13.54% down from its 52 week high and 67.10% up from its 52 week low.